Prostate cancer is the most common cancer among men in the United Kingdom. However, Macmillan revealed that prostate cancer diagnoses were down 29 per cent
between 2019 and 2020, meaning men weren't seeing their GPs to begin to get diagnosed. Therefore, it is of utmost importance to spot any symptoms and get checked,
as an early diagnosis can help not only increase survival rates, but also offer a more varied choice of treatment options.
As community pharmacy teams play a fundamental role in educating men who may be concerned about their health it vital to maximise trusted relationship with patients,
and it is crucial that pharmacists have access to the correct resources to direct men to seek prostate cancer guidance.
Prostate cancer often affects men who are over the age of 50. Those who are at a higher risk of prostate cancer also include those of African-Caribbean family
descent, if there has been a family history of the cancer, and poor weight and diet.
However, studies have found that community pharmacists play an important role in delivering programmes to improve levels of physical activity and diet of men with
prostate cancer.
Despite the pervasive nature of pain, affecting 93% of the global population annually and leaving one in three individuals in daily discomfort,
there exists a concerning reluctance to address and manage pain effectively. This leads to a heightened burden of suffering among people worldwide.
Join our complimentary 1-hour Pain Management Webinar, meticulously crafted to equip you and your team with vital strategies to comprehend, address,
and alleviate pain in your patients' lives. Delve into topics such as the pharmacist's evolving role, the significance of timely pain treatment, and
initiatives like Haleon's #ListenToPain campaign. This webinar is tailored for pharmacists in GB, especially those in community, practice, PCN, and hospital
settings. Don't miss this chance to enhance patient care and contribute positively to pain management. Register now to reserve your spot!
The Pharmacists' Defence Association (PDA) has written to the National Pharmacy Association (NPA) to highlight several important points regarding their
proposed "day of action" on 20 June 2024.
The NPA describes this initiative as a response to the "emergency across the community pharmacy sector."
In a letter addressed to NPA Chair Nick Kaye and Chief Executive Paul Rees, the PDA's director of pharmacy, Jay Badenhorst stressed the need for NPA members to
consider their obligations to staff and patients before participating in the planned actions.
He stated, "We are supportive of a new contractual framework for the community pharmacy sector."
"However, any actions taken must ensure the safety of patients and the operational integrity of pharmacies."
The PDA's letter also expressed concerns over the safety and operational impact of the proposed symbolic gestures, including turning off lights and blacking out
windows.
The 14th Annual Community Pharmacy Conference by Sigma Pharmaceuticals began on Monday, 25 February at Sun City, South Africa.
Dr. Bharat Shah, Manish Shah, and Kamal Shah, co-founders of the company, extended a warm welcome to the delegates in attendance at the event.
In a written message, Prime Minister Rishi Sunak extended his best wishes to all the participants attending the conference.
The message read: "This conference is timely as it coincides with the launch of the Pharmacy First, a new initiative launched across England that will enable
patients to receive treatments for seven common conditions directly from a pharmacist without the need for a GP appointment or prescription."
"We are all grateful for the tremendous contributions that pharmacists make to our NHS. The fantastic work you do is critical to the success of Pharmacy First
and many other initiatives."
During the coronavirus pandemic many people found themselves working from home, and this has continued to some extent in many businesses. A change in working
environment can bring challenges, one of which can be joint pain and discomfort.
Imagine you have gone from a busy office environment, meeting in boardrooms and visiting the canteen for a coffee, to working at home on your dining room table,
walking several feet to get a cup of tea and sitting back down again, this change in surroundings can have an impact on your joints.
Community pharmacists can be a source of knowledge to help individuals that may be suffering from joint complaints, this may be from the above scenario or just
general aches and pains that come from an office based role.
Firstly, it's important for us to know the effects of sitting down at a desk all day (not a scenario I'm sure many community pharmacists experience daily):
Back pain - is one of the most common complaints. This can be caused by bad posture while sitting too high, too low, or hunched over. While this may present as
just a soreness or discomfort, if not rectified and/or accessed this can lead to some serious health issues such as spinal compression, sciatica or spinal stenosis.
This Pharmacy First Common Ailments service will help patients seek treatment for seven common conditions directly from a pharmacy without the need
for a GP appointment or prescription.
Launching on 31 January next year although it is subject to IT being ready, the service will cover ailments including "sinusitis, sore throat, earache, infected
insect bites, impetigo, shingles, and uncomplicated urinary tract infections (UTIs)" in women.
People with symptoms of the above seven conditions will be supplied with a prescription-only treatment under a Patient Group Direction (PGD).
Patients seeking assistance at the pharmacy, whether walk-in or referred by NHS 111, GPs, or other sources, can receive consultations.
The new service includes self-referring patients plus referrals, and the Community Pharmacist Consultation Service (CPCS) will also be a part of it.
With the Pharmacy First services scheduled for launch end of this month, legislators explored the potential of community pharmacies to offer specific
diagnostic and treatment services in the second public evidence session of pharmacy inquiry this week (January 16).
The new service, which will enable pharmacists to offer advice and prescribe treatment for seven minor ailments, is expected to alleviate the pressure on the
NHS, reduce GP workload, and cut waiting lists.
But MPs and healthcare leaders also acknowledged that there's hesitancy and the mindset of 'GP first, not Pharmacy First' among members of the public.
"We must accept that many patients are used to seeing their GP as their first port of call for many health conditions. Pharmacy First is welcome, but there are
going to be some restrictions on how quickly some patients will want to take up some of those services, rather than seeing their GP," said William Pett, Head
of Policy, Public Affairs and Research, Healthwatch England.
The National Institute for Health and Care Excellence (NICE) has recommended elosulfase alfa for routine use in the NHS for the treatment of mucopolysaccharidosis type 4A (also known as MPS 4A and Morquio A syndrome).
Elosulfase alfa, also called Vimizin and made by BioMarin, becomes the first disease modifying treatment recommended by NICE for routine NHS use for people with this rare, severely life-limiting condition.
NICE's final draft guidance follows the collection of 'real-world' data from 69 people who received NHS-funded treatment since 2015 as part of a managed access agreement. Clinical trial evidence and data collected as part of the managed access agreement, along with expert clinical opinion, shows some long-term benefits with elosulfase alfa treatment which suggest it slows progression of MPS 4A.
Sobha Sharma Kandel wants community pharmacy teams up and down the country to be super responsive to emerging needs of their patients - by always being
pro-active rather than reactive.
"We know that every patient benefits from our proactive approaches - listening, asking questions, providing information and making clinical interventions when
appropriate.
"At a time when general practice is overstretched, community pharmacy must be relied upon as the frontline of the NHS when it comes to providing diagnosis,
treatment and continuous care in our communities to promote health and wellbeing of our patients."
Sobha believes Covid-19 has helped shift public perception of community pharmacies from being a place where one goes to collect a prescription to a hub where one
can access a range of healthcare advice and services.
"We are way more than just a shop where you can collect your medicines," she said, giving examples of how her interventions have helped reduce medication errors,
prevent harm and subsequently reduce cost of care.
She once saved a baby from getting overdosed with omeprazole when they had issues with gastroesophageal reflux. On another occasion, she managed a lady's high blood
pressure by finding equivalent medications to a combination dose prescribed by her doctor in another country.
Prostate cancer is the most common cancer among men in the United Kingdom, affecting nearly 50,000 men yearly. Combined with the challenges faced across
healthcare during COVID-19, new figures show that prostate cancer accounts for a third of cancers not treated due to the pandemic, with 14,000 'missing patients'
believed to have not undergone treatment since April 2020. It is more urgent than ever that men are encouraged to get checked, as any set-backs in diagnosis can
reduce the pathways available, in turn affecting health outcomes.
Community pharmacy teams play a crucial role in signposting the help available for men who may be concerned about their health. Therefore, it is vital that pharmacy
teams have access to the information they need to correctly direct men to seek prostate cancer guidance. By maximising the trusted relationship between patients and their pharmacists, more can be done to identify the warning signs, helping men to get an earlier diagnosis.
Eczema (atopic dermatitis), which affects up to 20 per cent of children, is one of the most common conditions pharmacists encounter, but don't underestimate
eczema. Generalised eczema may compromise health-related quality of life (HRQoL) more than several other chronic diseases, including asthma, epilepsy and diabetes.
Despite the impact on HRQoL, underuse of moisturisers and topical corticosteroids often leaves childhood eczema poorly controlled.
UK researchers recently reported that several factors contribute to the underuse of moisturisers and topical corticosteroids in children with eczema. For instance,
most of the 30 parents and carers interviewed felt that they had received little information about eczema.
The lack of understanding may help explain why some parents and carers expressed concerns, such as the risk of skin thinning, about topical corticosteroids. Some
were not convinced that moisturisers (strictly, an emollient is an ingredient of a moisturiser) reduced itch and maintained control of eczema. Some felt that
moisturisers' efficacy declined over time.
Parents and carers also admitted to "incomplete knowledge and skills" about managing eczema (such as whether they should apply moisturisers regularly) and
reluctance to manage eczema in collaboration with their child. Parents and carers wanted advice about using treatments and explanations of moisturisers' and
topical corticosteroids' mechanisms of action. The authors note that healthcare professionals could help identify and address gaps in knowledge.
A bout 15 to 30 per cent of the UK population suffers from hay fever and there has been a definite increase in the number of moderate to severe hay fever
sufferers, with sufferers experiencing more frequent and longer seasons.
And now that the government has announced its plans for the easing of lockdown, community pharmacists can expect to see many more of their patients presenting
with more severe symptoms than usual, as there will be more opportunities to spend time outside and be exposed to higher levels of pollen.
Symptoms
Common symptoms include sneezing, a runny stuffed up nose, itchy, watery eyes, nasal congestion and a general stuffed up feeling in the nose and throat.
Some experience itching around the face and mouth, with an itchy palette, and burning sensation in the throat. Headaches and wheezing can also occur, as well
as an overall achy feeling, or build-up of pressure in the facial area. The sinus area can become painful and constant nose blowing can leave sufferers with skin
irritation. This can lead to tiredness and affect sleep, which in turn reduces energy.
A new report published today (June 29) by the think tank Policy Exchange highlights key role for community pharmacy in management of primary-secondary care
interface.
The report called Medical Evolution has received cross-party support. It says an equivalent of 15 million GP appointments per year are spent dealing with issues
managing care between GP practices and hospitals.
Research from the think tank also finds 150,000 people could be on 'hidden' waiting lists (where a patient has been referred by a GP for further treatment, but
not included on official hospital waiting lists).
On the eve of the NHS Long Term Workforce Plan, the report calls for the development of 'interface specialists' - which could be undertaken by doctors, nurses or
community pharmacists to enable them to work more routinely across settings and to strategically plan interface working.
Usually as we head into winter, we can all predict what our patients will be asking us about. But, just like the rest of the year has been like no other in
community pharmacy, I'd expect this winter to be different too. This will present us with challenges, but also some great opportunities too.
One shift we have seen over the last seven months of Covid is that more and more people in the community are turning to their pharmacy for help, support and advice.
With our doors remaining open throughout the height of the pandemic, we've established ourselves firmly at the heart of local healthcare - a trend I'd expect to see
continue over the winter, especially now that a second wave, it seems, is upon us.
I think there's three different types of patients who we'll be seeing this winter coming to us for help and advice.
First, we'll see those with a simple winter illness - for example, a common cold. For these patients our advice will be focused around self-care and home treatments.
There is a wide range of products that we can recommend in the pharmacy from decongestants to combination products such as Night Nurse and nasal sprays.
Almost all community pharmacies in the West Midlands and East Midlands have begun treating people for seven common conditions, as part of the newly launched
Pharmacy First scheme.
NHS England on Sunday (4 February) revealed that more than 95 per cent of community pharmacies in the West Midlands (1130) and over 97 per cent in the East
Midlands (840) have joined the ground-breaking initiative.
The scheme allows highly trained pharmacists to assess and treat patients for sinusitis, sore throat, earache, infected insect bite, impetigo, shingles, and
uncomplicated urinary tract infections in women (under the age of 65) without the need for an appointment or prescription.
With this major expansion of pharmacy services, the health service is aiming to free up 10 million GP appointments a year, while making it easier and more
convenient for people to access care.
Community pharmacies in Cornwall have delivered more than 8000 face-to-face consultations over last 12 months.
Walk In Consultation Service (WICS) began 12 months ago when pharmacies in Cornwall started offering face-to-face consultations for a wide range of minor ailments,
and NHS treatment as required - the first service of its kind in England.
Cornwall & Isles of Scilly Scilly Local Pharmaceutical Committee (LPC) Chief Officer Nick Kaye joined Operations Manager Drew Creek in Parliament recently by invite
of Steve Double MP, St Austell and Newquay to meet with Minister for Health Neil O'Brien MP to present the service to them and Senior Civil Servants from DHSC and
NHSE with a view to rolling this service out nationally.
The data from these consultations show that over 6000 GP appointments were averted as a result of the service being available. After each consultation a record was
sent to the patient's GP for information.
Researchers from the London School of Hygiene & Tropical Medicine (LSHTM) have been tasked to evaluate the impact, safety and effectiveness of the
Pharmacy First service, which was launched across England in January 2024.
They have been awarded £2.4million by the National Institute for Health and Care Research (NIHR) to generate evidence on the new service that allows
pharmacies to provide advice and treatment for seven common conditions without the need for a GP appointment.
After consultation, if necessary, a community pharmacist can supply some prescription-only medicines to treat earache, sore throat, sinusitis, impetigo,
shingles, infected insect bites or uncomplicated urinary tract infections in women.
The LSHTM researcher team will be working together with experts at the UK Health Security Agency (UKHSA) and the Universities of Oxford, Manchester and
Nottingham on the project.
Dr Rebecca Glover, assistant professor in Antimicrobial Resistance at LSHTM, who will lead the three-year project, said they will evaluate "Pharmacy First's
impact on GPs and the wider NHS, pharmacy services and patients."
The Pharmacists' Defence Association (PDA) has expressed disappointment at the omission, once again, of the promised Employment Rights Bill omitted from the Queen's Speech earlier this week.
The Bill is pledged to strengthen day one employment rights and increase the productivity of businesses.
It set out plans which would protect and enhance workers' rights and aim to make the UK the best place in the world to work at. This included plans to introduce the right to request flexible working for around 2.2 million people in Great Britain - regardless of time served in a bid to modernise the way employees work.
The PDA said: "The Employment Rights Bill would have presented an opportunity to improve the ability for workers to obtain redress in the event of poor treatment or discrimination through the development of a single labour market enforcement body.
"Poor employment practices, such as insecure work through long-term zero-hours contracts, unilaterally changing workers' terms and conditions by terminating their
contracts and re-hiring them on new terms and conditions (also known as fire and rehire), and the sacking of workers without notice, as recently demonstrated by P
& O Ferries, could have been outlawed under new legislation."
The PSNC on Friday said it has warned the DHSC about the "very serious impact" of the limited supply of certain antibiotics on pharmacies who are "having to
chase stock, purchase without sight of any concession prices, and cope with increasing patient questions and abuse."
With higher than usual number of cases of scarlet fever, caused by invasive Group A Streptococci (iGAS) infections, being reported in children across the country,
supplies of antibiotics for Group A Strep treatment have seen a surge in demand, leading to limited supply at certain wholesalers and pharmacies.
PSNC has urged the DHSC to adopt measures that could help to manage the current crisis, such as allowing pharmacists more freedom to change strengths or formulations
without prescriber approval, outside of Serious Shortage Protocols.
It has also raised concerns on the significant rise in wholesale prices of many oral antibiotics as a result of the surge in demand and the ongoing supply
disruptions. PSNC also said they have received reports of some suppliers putting up their prices for any oral antibiotics they do have in stock.